Read + Share
Li D, Geng K, Hao Y, Gu J, et al. Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung
cancer models. J Clin Invest 2024 Dec 24:e174249. doi: 10.1172/JCI174249.
PMID: 39718828
|
 |
|
Li D, Geng K, Hao Y, Gu J, et al. Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung
cancer models. J Clin Invest 2024 Dec 24:e174249. doi: 10.1172/JCI174249.
PMID: 39718828
|
|
|
|